Experienced in Prostate Cancer

Dr. Muhammad I. Moid

Hematology Oncology
855 N Westhaven Dr, 
Oshkosh, WI 
Experienced in Prostate Cancer
855 N Westhaven Dr, 
Oshkosh, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Muhammad Moid is a Hematologist Oncology provider in Oshkosh, Wisconsin. Dr. Moid is rated as an Experienced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Acute Mountain Sickness, and Cavernous Sinus Thrombosis.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in WI
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

855 N Westhaven Dr, Oshkosh, WI 54904

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients With Refractory Metastatic Colorectal Cancer (mCRC)
Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients With Refractory Metastatic Colorectal Cancer (mCRC)
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Other, Drug
Study Drugs: Clobetasol propionate, Regorafenib
Study Phase: Phase 2
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2024
Intervention Type: Procedure, Other, Drug
Study Phase: Phase 2/Phase 3
Phase I Study of Thoracic Radiotherapy and Concurrent Chemotherapy With Soy Isoflavones in Stage III NSCLC (Non-Small Cell Lung Cancer) Patients
Phase I Study of Thoracic Radiotherapy and Concurrent Chemotherapy With Soy Isoflavones in Stage III NSCLC (Non-Small Cell Lung Cancer) Patients
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug, Dietary supplement, Radiation
Study Phase: Phase 1
View 3 Less Clinical Trials
Similar Doctors
Distinguished in Prostate Cancer
Dr. John D. Burfeind
Hematology Oncology | Oncology | Hematology
Distinguished in Prostate Cancer
Dr. John D. Burfeind
Hematology Oncology | Oncology | Hematology

The Medical College Of Wisconsin Inc

3200 Pleasant Valley Rd, 
West Bend, WI 
 (50.5 miles away)
262-836-7300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Burfeind is a Hematologist Oncology specialist and an Oncologist in West Bend, Wisconsin. Dr. Burfeind is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Burfeind is currently accepting new patients.

Advanced in Prostate Cancer
Dr. Anup K. Lahiry
Hematology Oncology | Hematology | Oncology
Advanced in Prostate Cancer
Dr. Anup K. Lahiry
Hematology Oncology | Hematology | Oncology
225 Memorial Dr, 
Berlin, WI 
 (17.6 miles away)
920-364-3600
Languages Spoken:
English, Bengali, Hindi, Spanish
See accepted insurances
Accepting New Patients

Anup Lahiry is a Hematologist Oncology specialist and a Hematologist in Berlin, Wisconsin. Dr. Lahiry is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Lahiry is currently accepting new patients.

Advanced in Prostate Cancer
Dr. Qiaofang L. Chen
Hematology Oncology | Hematology | Oncology
Advanced in Prostate Cancer
Dr. Qiaofang L. Chen
Hematology Oncology | Hematology | Oncology

Thedacare Incorporated

2500 E Capital Dr, 
Appleton, WI 
 (20.5 miles away)
920-364-3600
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Qiaofang Chen is a Hematologist Oncology specialist and a Hematologist in Appleton, Wisconsin. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma. Dr. Chen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moid's expertise for a condition
ConditionClose
      View All 73 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile